The Gene: An Intimate History

The author delves into his family's history of mental illness, particularly schizophrenia and bipolar disorder affecting generations. This personal journey ignited his scientific quest to understand heredity and the fundamental unit of information: the gene. He posits the gene alongside the atom and the byte as a transformative unit, shaping human pathology, behavior, and fate, while raising profound ethical questions about altering human identity.

This era traces the understanding of heredity from ancient theories to modern genetics. Early ideas like spermism and preformation gave way to Darwin’s natural selection, which lacked a mechanism for inheritance. Gregor Mendel’s work, demonstrating traits as discrete units, was overlooked until 1900. The concept of the gene emerged, alongside the dark practice of eugenics, aiming to "improve" humanity through selective breeding, culminating in tragic events like Buck v. Bell.

This period saw the material nature of the gene revealed. Thomas Hunt Morgan’s work with fruit flies linked genes to chromosomes, showing their physical location and linkage. Oswald Avery proved DNA, not protein, carried genetic information. The iconic double helix structure, deciphered by Watson, Crick, and Wilkins, explained DNA replication and established the central dogma of DNA to RNA to protein. This era shifted focus to gene physiology and regulation.

Geneticists learned to "write" and "read" genes. Paul Berg pioneered recombinant DNA, creating genetic hybrids. Herb Boyer and Stanley Cohen developed efficient cloning techniques using plasmids to amplify genes. Frederick Sanger's method enabled the "reading" of DNA sequences, cracking the genetic code. The discovery of introns in animal genes revealed modularity, allowing diverse protein production through RNA splicing. These technologies transformed genes into powerful experimental instruments.

Human genetics grappled with the complexity of diseases like normal pressure hydrocephalus, where multiple genes and environment interact. Victor McKusick pioneered cataloging hereditary disorders, highlighting incomplete penetrance and variable expressivity. Advances in prenatal diagnosis led to debates on "neo-eugenics." The mapping of the Huntington’s and cystic fibrosis genes, through techniques like linkage analysis and positional cloning, demonstrated the power of locating specific disease-causing genes within the vast human genome.

The inefficiency of single-gene mapping prompted the ambitious Human Genome Project (HGP) to sequence the entire human genome. Launched in 1989, it aimed to understand complex polygenic illnesses like cancer and schizophrenia. A fierce competition ensued with Craig Venter's private Celera Genomics, which championed shotgun sequencing. Despite disputes over data, a draft sequence was jointly announced in 2000, ushering in the "genomics" era and revealing surprising insights into human genetic complexity and gene count.

Post-HGP, genetics shifted to understanding normalcy and complex traits. Mitochondrial DNA studies supported the "Out of Africa" theory, showing limited human genetic diversity. The concept of race was largely debunked as a biological classifier. The SRY gene was identified as the master regulator of anatomical sex, while tragic cases like David Reimer demonstrated the strong biological component of gender identity, refuting purely nurture-based theories. Sexual orientation also showed a strong genetic influence.

This section introduces epigenetics, the study of how environment influences gene expression without altering DNA sequence. The Dutch "Hunger Winter" provided evidence of heritable epigenetic marks, showing how famine effects crossed generations. Pioneers like John Gurdon demonstrated the reversibility of cellular identity, while Mary Lyon observed X-chromosome inactivation. Epigenetic marks function as a cellular memory, explaining how chance events leave an imprint on our nature, enabling individuality and the potential for reinvention.

Early gene therapy efforts faced setbacks, notably the tragic death of Jesse Gelsinger, highlighting immune response challenges. However, the field revived, with successes in treating conditions like hemophilia B. The advent of CRISPR/Cas9 technology by Doudna and Charpentier brought unprecedented precision in DNA editing, raising urgent ethical concerns about germ-line modification and the potential for human enhancement. The power to read and write the human genome necessitates wisdom to navigate its implications for identity and future generations.

This section details the rapid advancements in genetic diagnosis, enabling prediction of illness and destiny. The identification of the BRCA1 gene created "previvors" facing agonising decisions about prophylactic measures. Research into schizophrenia revealed its complex polygenic nature, connecting creativity with mental illness and raising ethical dilemmas about eliminating genes. Preimplantation genetic diagnosis (PGD) offers powerful selection capabilities, challenging moral guidelines and raising concerns about dysgenic practices and the devolution of power to individuals.

This final section explores the profound ethical challenges of intentionally altering the human genome, moving from disease correction to potential enhancement. The distinction between non-germ-line therapy (affecting only the individual) and germ-line therapy (heritable changes) is critical. The precision of CRISPR/Cas9 reignited the debate, with scientists calling for moratoria on human embryonic stem cell editing. Early attempts in human embryos, despite failures, signaled the imminent capacity to create a "post-genomic" human, urging cautious stewardship to preserve human variation.